蛋白质检测市场规模、份额和成长分析(按类型、产品类型、技术、应用、最终用户和地区划分)-2026-2033年产业预测
市场调查报告书
商品编码
1899851

蛋白质检测市场规模、份额和成长分析(按类型、产品类型、技术、应用、最终用户和地区划分)-2026-2033年产业预测

Protein Assays Market Size, Share, and Growth Analysis, By Type (Dye-binding Assays, Copper-ion-based Assays), By Product (Reagents, Kits), By Technology, By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计到 2024 年,蛋白质检测市场规模将达到 71.2 亿美元,到 2025 年将达到 79.1 亿美元,到 2033 年将达到 185 亿美元,在预测期(2026-2033 年)内复合年增长率为 11.2%。

蛋白质检测市场正经历强劲成长,这主要得益于多种因素。对蛋白质体学研究的日益重视以及药物研发的进步显着推动了市场需求。此外,慢性病发病率的上升以及对精准诊断工具的需求也促进了市场扩张。高通量筛检等技术创新提高了蛋白质定量分析的效率。然而,某些检测方法的复杂性以及蛋白质系统固有的变异性等挑战可能会阻碍市场成长。北美在全球蛋白质检测市场中扮演着重要角色,占据了相当大的市场份额,这得益于其完善的研发基础设施和製药行业的持续发展。

蛋白质检测市场驱动因素

蛋白质体学研究和药物发现领域日益增长的兴趣,推动了对准确且环境友善的蛋白质定量方法的需求。随着製药和生物技术行业的持续发展,对可靠的蛋白质检测方法来评估药物疗效和安全性变得癒发重要。创新治疗方法的研发以及确保研究结果高品质这一迫切需求,进一步强化了这一趋势。因此,蛋白质检测技术的进步对于满足这些领域的需求至关重要,能够确保研究人员拥有进行可靠蛋白质分析所需的工具。

蛋白质测定市场限制因素

蛋白质检测市场的主要限制因素源于检测标准化方面的困难以及蛋白质结构固有的变异性,这阻碍了普遍适用且准确的定量分析的实现。此外,一些阳性检测方法的复杂性也限制了其广泛应用,尤其是在需要简单快速结果的环境中。这些挑战为研究人员和生产商带来了障碍,因此,开发更标准化、更易于使用且能满足各种应用需求并确保结果一致可靠的检测方法至关重要。应对这些挑战对于蛋白质检测方法在各个领域的发展和应用至关重要。

蛋白质测定市场趋势

蛋白质检测市场的一大趋势是开发高通量、多重检测系统,该系统能够同时分析多种蛋白质,以满足科学研究和临床应用中对高效、全面的蛋白质谱分析日益增长的需求。随着微流体和生物感测器等先进技术的兴起,这一趋势正在推动蛋白质检测调查方法的创新,在提高灵敏度的同时,最大限度地减少所需的样品量。这些进步正在改变蛋白质分析的格局,使检测更有效率且便捷,最终促进蛋白质研究领域的成长与发展。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数(2025)
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析

全球蛋白质检测市场规模(按类型和复合年增长率划分)(2026-2033 年)

  • 染料结合试验
  • 基于铜离子的检测​​方法
  • 基于试纸的检测
  • 其他蛋白质测定

全球蛋白质检测市场规模(按产品和复合年增长率划分)(2026-2033 年)

  • 试剂
  • 成套工具
  • 设备和配件

全球蛋白质检测市场规模(依技术及复合年增长率划分)(2026-2033 年)

  • 基于吸光度的蛋白质测定
  • 比色蛋白质测定
  • 基于萤光的蛋白质检测

全球蛋白质检测市场规模(按应用领域及复合年增长率划分)(2026-2033 年)

  • 药物发现与开发
  • 疾病诊断
  • 其他用途

全球蛋白质检测市场规模(依最终用户划分)及复合年增长率(2026-2033 年)

  • 製药和生物技术公司
  • 医院
  • 临床检查室
  • 学术机构
  • 其他最终用户

全球蛋白质检测市场规模及复合年增长率(2026-2033)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位(2025 年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析(2025 年)
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2023-2025年营收年比比较

主要企业简介

  • Thermo Fisher Scientific Inc.(USA)
  • Bio-Rad Laboratories, Inc.(USA)
  • Merck KGaA(Germany)
  • Abcam plc(UK)
  • Agilent Technologies, Inc.(USA)
  • Danaher Corporation(USA)
  • Roche Holding AG(Switzerland)
  • Siemens Healthineers AG(Germany)
  • PerkinElmer, Inc.(USA)
  • Bio-Techne Corporation(USA)
  • Promega Corporation(USA)
  • Lonza Group Ltd.(Switzerland)
  • Cell Signaling Technology, Inc.(USA)
  • Fujifilm Wako Pure Chemical Corporation(Japan)
  • Enzo Biochem, Inc.(USA)
  • Randox Laboratories Ltd.(UK)
  • DiaSorin SpA(Italy)
  • Cayman Chemical Company(USA)
  • Abnova Corporation(Taiwan)

结论与建议

简介目录
Product Code: SQMIG35D2203

Protein Assays Market size was valued at USD 7.12 Billion in 2024 and is poised to grow from USD 7.91 Billion in 2025 to USD 18.5 Billion by 2033, growing at a CAGR of 11.2% during the forecast period (2026-2033).

The Protein Assays market is experiencing robust growth fueled by several factors. A rising focus on proteomics research and advancements in drug discovery are significantly driving demand. Additionally, the increasing incidence of chronic diseases and the need for precise diagnostic tools further contribute to market expansion. Innovations in technology, such as high-throughput screening methods, improve the efficiency of protein quantification processes. However, challenges arise from the complexities of certain assays and the variability inherent in protein systems, which may hinder growth. North America commands a substantial market share, largely due to a well-established research infrastructure and ongoing developments in the pharmaceutical sector, positioning it as a key player in the global Protein Assays landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Protein Assays market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Protein Assays Market Segments Analysis

Global Protein Assays Market is segmented by Type, Product, Technology, Application, End User and region. Based on Type, the market is segmented into Dye-binding Assays, Copper-ion-based Assays, Test Strip-based Assays and Other Protein Assays. Based on Product, the market is segmented into Reagents, Kits and Instruments & Accessories. Based on Technology, the market is segmented into Absorbance-based Protein Assays, Colorimetric-based Protein Assays and Fluorescence-based Protein Assays. Based on Application, the market is segmented into Drug Discovery and Development, Disease Diagnosis and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals, Clinical Laboratories, Academic Institutes and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Protein Assays Market

The rising focus on proteomics research and drug discovery is driving the demand for accurate and environmentally friendly protein quantification methods. As the pharmaceutical and biotechnology industries continue to grow, the necessity for dependable protein assays to evaluate drug efficacy and safety becomes increasingly critical. This need is fueled by the development of innovative therapeutic approaches and the urgency to ensure high-quality results in research. Consequently, advancements in protein assay technologies are essential to meet the demands of these sectors, ensuring that researchers have the tools required for reliable protein analysis in their work.

Restraints in the Protein Assays Market

A significant constraint in the Protein Assays market arises from the difficulties linked to assay standardization and the inherent variability in protein structures, which hinder the achievement of universally applicable and accurate quantification. Additionally, the intricate nature of some positive assays can limit their widespread adoption, particularly in environments where simplicity and rapid results are essential. These challenges create barriers for researchers and manufacturers, making it crucial to develop more standardized and user-friendly assays that accommodate diverse applications while ensuring consistent and reliable outcomes. Addressing these issues is vital for the growth and acceptance of protein assays in various sectors.

Market Trends of the Protein Assays Market

The Protein Assays market is witnessing a significant trend towards the development of high-throughput and multiplexed assay systems that enable the simultaneous analysis of multiple proteins, catering to the increasing demand for efficiency and comprehensive protein profiling across research and clinical applications. Coupled with the rise of cutting-edge technologies such as microfluidics and biosensors, this trend drives innovation in protein assay methodologies, enhancing sensitivity while minimizing sample volume requirements. These advancements are reshaping the landscape of protein analysis, making assays more streamlined and accessible, ultimately fostering growth and expansion within the protein research community.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Protein Assays Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • Dye-binding Assays
  • Copper-ion-based Assays
  • Test Strip-based Assays
  • Other Protein Assays

Global Protein Assays Market Size by Product & CAGR (2026-2033)

  • Market Overview
  • Reagents
  • Kits
  • Instruments & Accessories

Global Protein Assays Market Size by Technology & CAGR (2026-2033)

  • Market Overview
  • Absorbance-based Protein Assays
  • Colorimetric-based Protein Assays
  • Fluorescence-based Protein Assays

Global Protein Assays Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Drug Discovery and Development
  • Disease Diagnosis
  • Other Applications

Global Protein Assays Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Pharmaceutical & Biotechnology Companies
  • Hospitals
  • Clinical Laboratories
  • Academic Institutes
  • Other End Users

Global Protein Assays Market Size & CAGR (2026-2033)

  • North America (Type, Product, Technology, Application, End User)
    • US
    • Canada
  • Europe (Type, Product, Technology, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Product, Technology, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Product, Technology, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Product, Technology, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Thermo Fisher Scientific Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abcam plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Holding AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Techne Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Promega Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lonza Group Ltd. (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cell Signaling Technology, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fujifilm Wako Pure Chemical Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Enzo Biochem, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Randox Laboratories Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DiaSorin S.p.A. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cayman Chemical Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abnova Corporation (Taiwan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations